You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Specific Receptor Sites for Chemotactic Peptides on Human Polymorphonuclear Leukocytes
Lewis T. Williams, Ralph Snyderman, Marilyn C. Pike and Robert J. Lefkowitz
Proceedings of the National Academy of Sciences of the United States of America
Vol. 74, No. 3 (Mar., 1977), pp. 1204-1208
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/66371
Page Count: 5
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Synthetic N-formylmethionyl peptides are chemotactic attractants for human polymorphonuclear leukocytes. The well-defined structure-activity relationship of these peptides in eliciting a chemotactic response suggests that the interaction of the peptides with a specific cellular binding site may initiate chemotaxis. By using tritiated N-formylmethionyl-leucyl-phenylalanine (fMet-Leu-[3H]Phe), a potent chemotactic peptide with high specific radioactivity, we have directly identified binding sites on human polymorphonuclear leukocytes. Binding of fMet-Leu-[3H]Phe to polymorphonuclear leukocytes is rapid (t1/2 < 2 min) and reversible. The equilibrium dissociation constant (KD) for the interaction of fMet-Leu-[3H]Phe with the binding site is 12-14 nM at 37 degrees. The number of binding sites is approximately 2000 per cell. The specificity of the binding sites for a series of N-formylmethionyl peptides exactly reflects the specificity of the chemotactic response to the peptides in that they compete for the binding sites and initiate chemotaxis with the same order of potency (fMet-Leu-Phe > fMet-Met-Met > fMet-Phe > fMet-Leu > fMet). fPhe-Met is a competitive antagonist of the chemotactic activity of N-formylmethionyl peptides and has a calculated KD of 6 × 10-5 M. fPhe-Met also half-maximally inhibits binding of fMet-Leu-[3H]Phe at a concentration of 9 × 10-5 M. Of several circulating cell types tested, the specific activity of fMet-Leu-[3H]Phe binding was the highest in polymorphonuclear leukocytes. No binding of fMet-Leu-[3H]Phe to human erythrocytes could be detected. These data indicate that fMet-Leu-[3H]Phe can be used to identify binding sites for chemotactic peptides on human polymorphonuclear leukocytes. It is likely that these binding sites initiate the specific response of motile cells to N-formylmethionyl peptides.
Proceedings of the National Academy of Sciences of the United States of America © 1977 National Academy of Sciences